Clinical trials - Press Releases

Date	Title	Company
10-Aug-2020	Chi-Med Plans to Submit Marketing Authorization Application for Surufatinib Following Scientific Advice from EMA’s CHMP	Hutchison China MediTech Limited
10-Aug-2020	Significant clinical, financial and personnel milestones demonstrate strong value progression	Syncona Ltd
04-Aug-2020	Teckro Looks to Future on 5th Anniversary: Expands Leadership Team to Accelerate Growth	Teckro
04-Aug-2020	New Industry Research Finds that Investigative Sites Use Unsophisticated Approaches to Access Protocol Instructions, Despite Availability of Newer Technologies	Teckro
04-Aug-2020	The new Marketplace for Pharma Business Opportunities is now online	Raucon
03-Aug-2020	Insilico Biotechnology AG reports progress on the use of methanol for the sustainable production of fine chemicals	Insilico Biotechnology AG
03-Aug-2020	Tiziana Announces Pricing of U.S. Follow-On Offering of ADSs Raising $57.25 million	Tiziana Life Sciences plc
03-Aug-2020	Oxford Biomedica Signs Development, Manufacture & License Agreement with Beam Therapeutics Inc., for LentiVector® Platform for Next Generation CAR-T Therapeutics	Oxford Biomedica
03-Aug-2020	UCL Technology Fund announces first close of £100m Fund 2	UCL Technology Fund
03-Aug-2020	Enterome scientists contribute to extensive new genomic and proteomic catalog to enhance analysis of the gut microbiome and understanding of its role in human health	ENTEROME SA,
03-Aug-2020	Novartis Cosentyx® receives EU approval for first-line systemic treatment in pediatric psoriasis	Novartis
03-Aug-2020	ASLAN PHARMACEUTICALS APPOINTS KENNETH KOBAYASHI, MD, AS CHIEF MEDICAL OFFICER	ASLAN Pharmaceuticals
03-Aug-2020	Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID)	Eli Lilly
03-Aug-2020	Panthera’s UK oncology clinical trial sites open for studies	Panthera Biopartners
31-Jul-2020	Horizon Discovery Group plc Half Year Trading Update	Horizon Discovery Group plc
31-Jul-2020	Alliance for Regenerative Medicine Calls for Multi-Stakeholder Pan-European Initiative to Fast-Track Real World Evidence in Support of Patient Access to Advanced Therapies	The Alliance for Regenerative Medicine (ARM)
31-Jul-2020	Novadip Biosciences to Present at the LifeSci Partners Summer Symposium	Novadip Biosciences
31-Jul-2020	AMRYT TO HOST KEY OPINION LEADER CALL ON EPIDERMOLYSIS BULLOSA DISEASE LANDSCAPE	Amryt
31-Jul-2020	Enterome initiates first clinical trial with EO2401 – an innovative microbiome-antigen (‘OncoMimic’) based cancer immunotherapy candidate targeting aggressive brain cancer	Enterome
31-Jul-2020	Helsinn Advanced Synthesis opens its largest dedicated Anticancer bay	Helsinn Group